AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 114 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $5,526,000 | +2.4% | 261,771 | -0.8% | 0.34% | +1.5% |
| Q1 2019 | $5,394,000 | -18.7% | 264,004 | -20.8% | 0.34% | -17.2% |
| Q4 2018 | $6,636,000 | -2.1% | 333,483 | -5.3% | 0.41% | +28.8% |
| Q3 2018 | $6,776,000 | +13.2% | 352,170 | -10.2% | 0.32% | +12.5% |
| Q2 2018 | $5,986,000 | +22.0% | 392,296 | +49.9% | 0.28% | +16.6% |
| Q1 2018 | $4,907,000 | – | 261,692 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Campbell & CO Investment Adviser LLC | 11,961 | $219,000 | 0.13% |
| FEDERATED HERMES, INC. | 3,441,367 | $63,046,000 | 0.12% |
| CORNERCAP INVESTMENT COUNSEL INC | 54,751 | $1,003,000 | 0.11% |
| GSA CAPITAL PARTNERS LLP | 34,425 | $631,000 | 0.10% |
| First Trust Direct Indexing L.P. | 11,913 | $218,000 | 0.06% |
| Summit Global Investments | 47,546 | $871,000 | 0.06% |
| WINTON GROUP Ltd | 49,766 | $912,000 | 0.05% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 397,950 | $7,290,000 | 0.05% |
| AIGEN INVESTMENT MANAGEMENT, LP | 16,077 | $295,000 | 0.04% |
| EXCHANGE TRADED CONCEPTS, LLC | 52,334 | $959,000 | 0.04% |